Selegiline News and Research

RSS
Study finds link between extended use MAO-B inhibitors and slow clinical decline in PD patients

Study finds link between extended use MAO-B inhibitors and slow clinical decline in PD patients

New therapeutic targets release mechanisms in reactive astrocytes for treatment of Alzheimer's disease

New therapeutic targets release mechanisms in reactive astrocytes for treatment of Alzheimer's disease

Sagene completes SPI-1972 pre-IND meeting with FDA for erectile dysfunction

Sagene completes SPI-1972 pre-IND meeting with FDA for erectile dysfunction

Clinicians should assess sleep-wake disturbances to understand physiology of Parkinson's disease

Clinicians should assess sleep-wake disturbances to understand physiology of Parkinson's disease

New systematic study for managing treatment-resistant bipolar depression

New systematic study for managing treatment-resistant bipolar depression

Four Pharma companies underpay Medicaid rebate obligations, pay $124M to resolve allegations

Four Pharma companies underpay Medicaid rebate obligations, pay $124M to resolve allegations

Parkinson's patients with higher urate levels in their blood and CSF had slower functional decline

Parkinson's patients with higher urate levels in their blood and CSF had slower functional decline

Practice parameters discuss treatment for narcolepsy, other hypersomnias of central origin

Practice parameters discuss treatment for narcolepsy, other hypersomnias of central origin

Mylan granted U.S. patent for transdermal product

Mylan granted U.S. patent for transdermal product

Parkinson's patients stomach new drug better than conventional meds

Parkinson's patients stomach new drug better than conventional meds

Benefits of MAO-B inhibitors are small but may be worthwhile in some patients with early Parkinson's disease

Benefits of MAO-B inhibitors are small but may be worthwhile in some patients with early Parkinson's disease